New Introducing new AI productivity and analytics tools

ASSESS supports health technology innovators and startups

Discover how a global network of experts can support your organization to achieve key milestones, including making foundational strategic decisions, achieving investment, obtaining trial, and securing adoption.

about
Photo by David Billings on Unsplash
Your Milestones

Which milestones in your commercialization journey can ASSESS help you achieve next?

Foundational decisions determine technology commercial potential and probability of success.

ASSESS supports innovators with key insights at a time when there is opportunity to make decisions that focus R&D, commercialization, and evidence generation efforts on those that have the highest value from the perspective of the payer and end user.

about
Photo by Jason Goodman on Unsplash
team
Photo by Adib Hussain on Unsplash
team
Photo by Austin Distel on Unsplash
team

Clear articulation of the value of technology, and how it is likely to be considered by payers, strengthens investor confidence and capital raise success.

ASSESS supports innovators with early value assessment and health economic analysis to quantify the Adoption Case for technology in development, helping investors to deepen understanding of technology commercial potential, its attractiveness to payers, and its pricing power.

about

Life sciences technology must be prioritized for trial in health systems considering adoption, and trials must be appropriately structured to inform procurement decision-making.

ASSESS supports innovators to make the Trial Case for technology in development, helping health systems to understand the size, causes and implications of the problem technology is intended to solve, and how to properly trial it to understand technology economic impact.

Health care payers require evidence of economic value for technologies being considered for adoption.

ASSESS supports innovators to articulate the Procurement Case for market-ready technology, utilizing robust health economic modelling and analysis of trial data to quantify the value of the technology and its budget impact.

Where uncertainty remains post trial regarding real-world effectiveness, guidance can be provided on additional on-market evidence to collect to inform scale and spread decisions.

team
team
Photo by CDC on Unsplash
team
Experience

Some companies we've worked with across the health technology landscape

logo logo logo logo logo logo logo logo logo logo logo logo logo logo logo logo
Your Questions

What key questions in your commercialization journey can ASSESS help you answer?

At each stage of the Commercialization Journey, life sciences innovators have key questions that can be answered with support of those with expertise in health technology assessment and health economics.

Key Stage Questions

Answers to these questions help inform strategy, focus evidence generation activities on those that are the most valuable, and produce analyses and evidence to support communication with investors, end users and payers.

Concept Stage

What is the most valuable lead or beachhead clinical application for the technology?

Learn more
Very Early Stage

What is the technology commercial potential and evidence requirements to bring to market?

Learn more
Early Stage

What is the potential for the technology to be attractive to payers, and at what price?

Learn more
Mid Stage

How can health system be engaged to trial technology, and how can trials be structured to effectively prove economic value?

Learn more
Late Stage

How can data from trial be analyzed and packaged for submission to procurement?

Learn more
Testimonials

What our clients say

Careteam

“We are extremely satisfied with the work done and have already recommended the service to others.

This program has been invaluable to us, I can't say enough to recommend it - this kind of evidence is vital to digital health sales and incredibly hard to find. We plan to include the service in major research projects in the future to demonstrate the economic impact of our interventions.”

Rob Attwell
COO
Nura Medical

“The ASSESS project provided NURA with robust, real-world data to substantiate the health economic rationale underlying our pricing structure. This data will be instrumental in presenting our value proposition to hospital decision-makers and investors.”

Georgia Powell
Co-founder & CEO
Greenspace

“Our team was very happy with the level of thoroughness and rigor of the work and deliverables from the ASSESS team, as well as their communication. We would recommend the service to other organizations given the ease of working with the ASSESS team and the rigor of their work.”

Tanya Scarapicchia
Tenomix

“The economic evaluation that was conducted helped with initial conversations with our investors and it ultimately led to the closure of our first financing round.

The model conducted by the ASSESS team also really gave my team and I a great starting point to truly understand the complete economics behind the problem we are solving and what types of clinical studies that we need to build in order to demonstrate the economic value proposition of the technology.”

Saumik Biswas
CEO, Founder
CarePal

“The economic modeling report is a foundational tool that supports our firm’s growth by providing data-driven insights for investors, internal decision-makers, and potential clients. I am highly satisfied and would recommend the service to other firms.”

Cindy Sim
CEO
Proton

“We enjoyed working with and recommend ASSESS. They helped us to complete an early economic analysis, including a variety of sensitivity analyses, to assist us to demonstrate that our product is extremely cost effective in our target population.”

Rory St. Clair
VP Operations
Why Us

First-in-World approach

For the first time, ASSESS has created a mechanism via the ASSESS Project to enable a global network of accomplished experts to contribute to the commercialization success of innovative companies, ensuring the right skill set, experience, target market and therapeutic area knowledge is matched to the support needs of innovators.

Global leaders

A global community of leading experts assembled to support innovative companies

ASSESS has assembled an online global community of those with expertise and experience in assessing and modelling the value of new technologies, how they can integrate into complex care pathways, and the evidence required for patients to gain access to them and have them utilized by healthcare professionals.

By leveraging the ASSESS Project, we have shifted the paradigm of obtaining opinions from these professionals from the end of the product development cycle to much earlier in the process, when there is opportunity to focus resources on high value technology, and more explicitly design value for end users and payers into product and evidence development.

Global Community Thought Leaders Early Advice Focused Development
about
Photo by Product School on Unsplash
about
Photo by Clay Banks on Unsplash
Collaboration

Work together across all phases of your journey

The intent for ASSESS is to engage and to work continuously with innovators, in a longitudinal fashion, providing services and guidance from different types of expertise of the assembled community as the technology matures, as well as cost-efficient updates to previous analyses and modelling as new data from trial becomes available.

Analyses and evidence generated by the expert community is used to support communication and referral to Investor and Trial Networks as companies progress along their commercialization journey, accelerating the path to investment, trial and adoption.

  • Continuous support and guidance
  • Assessment & insights along the path to market
  • Expertise aligned to innovator stage needs
  • Communication vehicles and referrals to partner networks
Our Network

Building a worldwide partner network

We are building a worldwide network of partners that contribute to the success of innovative companies, including grant funding, investor, and trial networks that we work with to support acceleration of new technologies to market.

logo
logo
logo
logo
logo
logo
logo
logo
logo
logo
logo
ASSESS's services are supported in part by funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).
Join our Partner Network

Want to explore engaging with ASSESS?

Contact us to share the milestones you require support to achieve, or to answer the burning questions you have, and to understand how we can help.

Let's talk